Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054310238> ?p ?o ?g. }
- W2054310238 endingPage "1586" @default.
- W2054310238 startingPage "1579" @default.
- W2054310238 abstract "In Brief BACKGROUND: Many inhaled anesthetics inhibit voltage-gated sodium channels at clinically relevant concentrations, and suppression of neurotransmitter release by these anesthetics results, at least partly, from decreased presynaptic sodium channel activity. Volatile aromatic anesthetics can inhibit N-methyl-d-aspartate (NMDA) receptor function and enhance γ-amino butyric acid A receptor function, but these effects depend strongly on the chemical properties of the aromatic compounds. In the present study we tested whether diverse aromatic anesthetics consistently inhibit sodium channel function. METHODS: We studied the effect of eight aromatic anesthetics on Nav1.2 sodium channels with β1 subunits, using whole-cell, two-electrode voltage-clamp techniques in Xenopus oocytes. RESULTS: All aromatic anesthetics inhibited INa (sodium currents) at a holding potential which produce half-maximal current (V1/2) (partial depolarization); inhibition was modest with 1,3,5-trifluorobenzene (8% ± 2%), pentafluorobenzene (13% ± 2%), and hexafluorobenzene (13% ± 2%), but greater with benzene (37% ± 2%), fluorobenzene (39% ± 2%), 1,2-difluorobenzene (48% ± 2%), 1,4-difluorobenzene (31 ± 3%), and 1,2,4-trifluorobenzene (33% ± 1%). Such dichotomous effects were noted by others for NMDA and γ-aminobutyric acid A receptors. Parallel, but much smaller inhibition, was found for INa at a holding potential which produced near maximal current (−90 mV) (VH-90), and hexafluorobenzene caused small (6% ± 1%) enhancement of this current. These changes in sodium channel function were correlated with effectiveness for inhibiting NMDA receptors, with lipid solubility of the compounds, with molecular volume, and with cation-π interactions. CONCLUSION: Aromatic compounds vary in their actions on the kinetics of sodium channel gating and this may underlie their variable inhibition. The range of inhibition produced by minimum alveolar anesthetic concentration concentrations of inhaled anesthetics indicates that sodium channel inhibition may underlie the action of some of these anesthetics, but not others. IMPLICATIONS: Aromatic anesthetics can block N-methyl-d-aspartate receptors and enhance γ-aminobutyric acid A receptor responses. The present report finds various effects of these compounds on sodium channels. Although volatile aromatic anesthetics are not used clinically, exploring their effects on ion channels may aid in understanding the mechanisms of clinical inhaled anesthetic actions." @default.
- W2054310238 created "2016-06-24" @default.
- W2054310238 creator A5026287401 @default.
- W2054310238 creator A5051991684 @default.
- W2054310238 creator A5082855062 @default.
- W2054310238 date "2008-11-01" @default.
- W2054310238 modified "2023-10-14" @default.
- W2054310238 title "The Effects of Volatile Aromatic Anesthetics on Voltage-Gated Na+ Channels Expressed in Xenopus Oocytes" @default.
- W2054310238 cites W1600620818 @default.
- W2054310238 cites W1633272553 @default.
- W2054310238 cites W1668093331 @default.
- W2054310238 cites W1983187084 @default.
- W2054310238 cites W1984180589 @default.
- W2054310238 cites W1988782252 @default.
- W2054310238 cites W2007845355 @default.
- W2054310238 cites W2015041117 @default.
- W2054310238 cites W2017183797 @default.
- W2054310238 cites W2021298026 @default.
- W2054310238 cites W2034954698 @default.
- W2054310238 cites W2042460710 @default.
- W2054310238 cites W2050207993 @default.
- W2054310238 cites W2055241837 @default.
- W2054310238 cites W2059292983 @default.
- W2054310238 cites W2067326992 @default.
- W2054310238 cites W2068723023 @default.
- W2054310238 cites W2081025398 @default.
- W2054310238 cites W2092963962 @default.
- W2054310238 cites W2101986800 @default.
- W2054310238 cites W2115322253 @default.
- W2054310238 cites W2130972481 @default.
- W2054310238 cites W2145822280 @default.
- W2054310238 cites W2156798177 @default.
- W2054310238 cites W2159332152 @default.
- W2054310238 cites W2169478814 @default.
- W2054310238 cites W4212963857 @default.
- W2054310238 doi "https://doi.org/10.1213/ane.0b013e318184b966" @default.
- W2054310238 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2575119" @default.
- W2054310238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18931215" @default.
- W2054310238 hasPublicationYear "2008" @default.
- W2054310238 type Work @default.
- W2054310238 sameAs 2054310238 @default.
- W2054310238 citedByCount "17" @default.
- W2054310238 countsByYear W20543102382012 @default.
- W2054310238 countsByYear W20543102382014 @default.
- W2054310238 countsByYear W20543102382015 @default.
- W2054310238 countsByYear W20543102382016 @default.
- W2054310238 countsByYear W20543102382017 @default.
- W2054310238 countsByYear W20543102382019 @default.
- W2054310238 countsByYear W20543102382020 @default.
- W2054310238 crossrefType "journal-article" @default.
- W2054310238 hasAuthorship W2054310238A5026287401 @default.
- W2054310238 hasAuthorship W2054310238A5051991684 @default.
- W2054310238 hasAuthorship W2054310238A5082855062 @default.
- W2054310238 hasBestOaLocation W20543102381 @default.
- W2054310238 hasConcept C104317684 @default.
- W2054310238 hasConcept C12554922 @default.
- W2054310238 hasConcept C147944092 @default.
- W2054310238 hasConcept C170493617 @default.
- W2054310238 hasConcept C178790620 @default.
- W2054310238 hasConcept C185592680 @default.
- W2054310238 hasConcept C2776840056 @default.
- W2054310238 hasConcept C2777691172 @default.
- W2054310238 hasConcept C2779535977 @default.
- W2054310238 hasConcept C2779843069 @default.
- W2054310238 hasConcept C4141045 @default.
- W2054310238 hasConcept C50952357 @default.
- W2054310238 hasConcept C537181965 @default.
- W2054310238 hasConcept C55493867 @default.
- W2054310238 hasConcept C67018056 @default.
- W2054310238 hasConcept C71240020 @default.
- W2054310238 hasConcept C71924100 @default.
- W2054310238 hasConcept C86803240 @default.
- W2054310238 hasConcept C98274493 @default.
- W2054310238 hasConceptScore W2054310238C104317684 @default.
- W2054310238 hasConceptScore W2054310238C12554922 @default.
- W2054310238 hasConceptScore W2054310238C147944092 @default.
- W2054310238 hasConceptScore W2054310238C170493617 @default.
- W2054310238 hasConceptScore W2054310238C178790620 @default.
- W2054310238 hasConceptScore W2054310238C185592680 @default.
- W2054310238 hasConceptScore W2054310238C2776840056 @default.
- W2054310238 hasConceptScore W2054310238C2777691172 @default.
- W2054310238 hasConceptScore W2054310238C2779535977 @default.
- W2054310238 hasConceptScore W2054310238C2779843069 @default.
- W2054310238 hasConceptScore W2054310238C4141045 @default.
- W2054310238 hasConceptScore W2054310238C50952357 @default.
- W2054310238 hasConceptScore W2054310238C537181965 @default.
- W2054310238 hasConceptScore W2054310238C55493867 @default.
- W2054310238 hasConceptScore W2054310238C67018056 @default.
- W2054310238 hasConceptScore W2054310238C71240020 @default.
- W2054310238 hasConceptScore W2054310238C71924100 @default.
- W2054310238 hasConceptScore W2054310238C86803240 @default.
- W2054310238 hasConceptScore W2054310238C98274493 @default.
- W2054310238 hasIssue "5" @default.
- W2054310238 hasLocation W20543102381 @default.
- W2054310238 hasLocation W20543102382 @default.
- W2054310238 hasLocation W20543102383 @default.
- W2054310238 hasLocation W20543102384 @default.
- W2054310238 hasLocation W20543102385 @default.